Neurodon LLC

Focus is on Investigating Therapeutics for Metabolic Disorders

Neurodon LLC, a leader in disease-modifying treatments for neurodegenerative diseases like Parkinson's, Alzheimer's, and ALS, has published another breakthrough, this time targeting stroke and traumatic brain injury (TBI).

Neurodon LLC has recently published a breakthrough study that paves the way for a new, effective way to treat Parkinson's disease. The novel strategy focuses on a process called endoplasmic reticulum stress, or ER stress.